Effect of acute modafinil ingestion on cognitive and physical performance following mental exertion

Ben Rattray, Kristy Martin, Alex Hewitt, Gabrielle Cooper, Warren McDonald

Research output: Contribution to journalArticle

Abstract

Objective: Modafinil is a psychostimulant that has been shown to enhance cognitive and physical performance. Given its long half-life, it may provide operational advantages if it can improve tolerance to the deleterious effects of prolonged mental exertion. Methods: Physically active males (n = 13, 23 ± 4 years, peak oxygen consumption 45.3 ± 3.2 ml kg-1 min-1 ) took part in a placebo controlled, double-blind randomised crossover study to investigate if modafinil could improve cognitive and physical performance following a prolonged period of mental exertion. Results: Overall modafinil improved performance on a task of executive function over time (p = .023; η2 = 0.376) but did not improve subsequent physical endurance performance (mean difference 2.3 ± 11.5%, p = .50), despite improvement in 10 out of the 13 participants. Task demand was reported as lower with modafinil, although perceptual measures of fatigue and motivation did not consistently improve. Heart rate during submaximal exercise was higher (134 ± 11 vs. 119 ± 14 bpm, p < .001), and sleep was reduced (5.5 ± 1.4 vs. 7.5 ± 1.4 hr, p < .001) and less efficient (64 ± 13 vs. 83 ± 9%, p < .001) compared with placebo. Conclusions: Operationally, modafinil may offer advantages given the established longer half-life than other psychostimulants, despite the variable response. The impact of higher heart rates and disrupted sleep on performance must also be considered.

Original languageEnglish
Article number2700
Pages (from-to)1-9
Number of pages9
JournalHuman Psychopharmacology
Volume34
Issue number4
DOIs
Publication statusPublished - Jul 2019

Fingerprint

Eating
Half-Life
Sleep
Physical Endurance
Heart Rate
Placebos
Executive Function
Oxygen Consumption
Cross-Over Studies
Fatigue
Motivation
modafinil

Cite this

@article{3c1f8b123d2d4265be1394fc3e1dfefd,
title = "Effect of acute modafinil ingestion on cognitive and physical performance following mental exertion",
abstract = "Objective: Modafinil is a psychostimulant that has been shown to enhance cognitive and physical performance. Given its long half-life, it may provide operational advantages if it can improve tolerance to the deleterious effects of prolonged mental exertion. Methods: Physically active males (n = 13, 23 ± 4 years, peak oxygen consumption 45.3 ± 3.2 ml kg-1 min-1 ) took part in a placebo controlled, double-blind randomised crossover study to investigate if modafinil could improve cognitive and physical performance following a prolonged period of mental exertion. Results: Overall modafinil improved performance on a task of executive function over time (p = .023; η2 = 0.376) but did not improve subsequent physical endurance performance (mean difference 2.3 ± 11.5{\%}, p = .50), despite improvement in 10 out of the 13 participants. Task demand was reported as lower with modafinil, although perceptual measures of fatigue and motivation did not consistently improve. Heart rate during submaximal exercise was higher (134 ± 11 vs. 119 ± 14 bpm, p < .001), and sleep was reduced (5.5 ± 1.4 vs. 7.5 ± 1.4 hr, p < .001) and less efficient (64 ± 13 vs. 83 ± 9{\%}, p < .001) compared with placebo. Conclusions: Operationally, modafinil may offer advantages given the established longer half-life than other psychostimulants, despite the variable response. The impact of higher heart rates and disrupted sleep on performance must also be considered.",
keywords = "Stroop, cognitive control, endurance, pharmaceutical, time to exhaustion",
author = "Ben Rattray and Kristy Martin and Alex Hewitt and Gabrielle Cooper and Warren McDonald",
note = "{\circledC} 2019 John Wiley & Sons",
year = "2019",
month = "7",
doi = "10.1002/hup.2700",
language = "English",
volume = "34",
pages = "1--9",
journal = "Human Psychopharmacology",
issn = "0885-6222",
publisher = "John Wiley & Sons",
number = "4",

}

Effect of acute modafinil ingestion on cognitive and physical performance following mental exertion. / Rattray, Ben; Martin, Kristy; Hewitt, Alex; Cooper, Gabrielle; McDonald, Warren.

In: Human Psychopharmacology, Vol. 34, No. 4, 2700, 07.2019, p. 1-9.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of acute modafinil ingestion on cognitive and physical performance following mental exertion

AU - Rattray, Ben

AU - Martin, Kristy

AU - Hewitt, Alex

AU - Cooper, Gabrielle

AU - McDonald, Warren

N1 - © 2019 John Wiley & Sons

PY - 2019/7

Y1 - 2019/7

N2 - Objective: Modafinil is a psychostimulant that has been shown to enhance cognitive and physical performance. Given its long half-life, it may provide operational advantages if it can improve tolerance to the deleterious effects of prolonged mental exertion. Methods: Physically active males (n = 13, 23 ± 4 years, peak oxygen consumption 45.3 ± 3.2 ml kg-1 min-1 ) took part in a placebo controlled, double-blind randomised crossover study to investigate if modafinil could improve cognitive and physical performance following a prolonged period of mental exertion. Results: Overall modafinil improved performance on a task of executive function over time (p = .023; η2 = 0.376) but did not improve subsequent physical endurance performance (mean difference 2.3 ± 11.5%, p = .50), despite improvement in 10 out of the 13 participants. Task demand was reported as lower with modafinil, although perceptual measures of fatigue and motivation did not consistently improve. Heart rate during submaximal exercise was higher (134 ± 11 vs. 119 ± 14 bpm, p < .001), and sleep was reduced (5.5 ± 1.4 vs. 7.5 ± 1.4 hr, p < .001) and less efficient (64 ± 13 vs. 83 ± 9%, p < .001) compared with placebo. Conclusions: Operationally, modafinil may offer advantages given the established longer half-life than other psychostimulants, despite the variable response. The impact of higher heart rates and disrupted sleep on performance must also be considered.

AB - Objective: Modafinil is a psychostimulant that has been shown to enhance cognitive and physical performance. Given its long half-life, it may provide operational advantages if it can improve tolerance to the deleterious effects of prolonged mental exertion. Methods: Physically active males (n = 13, 23 ± 4 years, peak oxygen consumption 45.3 ± 3.2 ml kg-1 min-1 ) took part in a placebo controlled, double-blind randomised crossover study to investigate if modafinil could improve cognitive and physical performance following a prolonged period of mental exertion. Results: Overall modafinil improved performance on a task of executive function over time (p = .023; η2 = 0.376) but did not improve subsequent physical endurance performance (mean difference 2.3 ± 11.5%, p = .50), despite improvement in 10 out of the 13 participants. Task demand was reported as lower with modafinil, although perceptual measures of fatigue and motivation did not consistently improve. Heart rate during submaximal exercise was higher (134 ± 11 vs. 119 ± 14 bpm, p < .001), and sleep was reduced (5.5 ± 1.4 vs. 7.5 ± 1.4 hr, p < .001) and less efficient (64 ± 13 vs. 83 ± 9%, p < .001) compared with placebo. Conclusions: Operationally, modafinil may offer advantages given the established longer half-life than other psychostimulants, despite the variable response. The impact of higher heart rates and disrupted sleep on performance must also be considered.

KW - Stroop

KW - cognitive control

KW - endurance

KW - pharmaceutical

KW - time to exhaustion

UR - http://www.scopus.com/inward/record.url?scp=85067368640&partnerID=8YFLogxK

UR - http://www.mendeley.com/research/effect-acute-modafinil-ingestion-cognitive-physical-performance-following-mental-exertion

U2 - 10.1002/hup.2700

DO - 10.1002/hup.2700

M3 - Article

VL - 34

SP - 1

EP - 9

JO - Human Psychopharmacology

JF - Human Psychopharmacology

SN - 0885-6222

IS - 4

M1 - 2700

ER -